Notice2022-21422
National Heart, Lung, and Blood Institute; Notice of Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 4, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 191 (Tuesday, October 4, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 191 (Tuesday, October 4, 2022)]
[Notices]
[Pages 60178-60179]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-21422]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Heart,
Lung, and Blood Advisory Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
as well as those who need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting. The open session
will be videocast and can be accessed from the NIH Videocast website
<a href="https://www.nhlbi.nih.gov/about/advisory-and-peer-review-committees/advisory-council">https://www.nhlbi.nih.gov/about/advisory-and-peer-review-committees/advisory-council</a>. Please note, the link to the videocast meeting will
be posted within a week of the meeting date.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Advisory
Council.
Date: October 25, 2022.
Closed: 9:00 a.m. to 10:00 a.m.
Agenda: To Review and Evaluate Grant Applications.
Place: National Institutes of Health, Porter Neuroscience
Research Center, 35 Convent Drive, Building 35A, Bethesda, MD 20892.
Open: 10:00 a.m. to 3:00 p.m.
Agenda: To Discuss Program Policies and Issues.
Place: National Institutes of Health, Porter Neuroscience
Research Center, 35 Convent Drive, Building 35A, Bethesda, MD 20892.
Contact Person: Laura K. Moen, Ph.D., Director, Division of
Extramural Research Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
206-Q, Bethesda, MD 20892,301-827-5517, <a href="/cdn-cgi/l/email-protection#513c3e343f3d113c30383d7f3f38397f363e27"><span class="__cf_email__" data-cfemail="670a0802090b270a060e0b49090e0f49000811">[email protected]</span></a>.
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
[[Page 60179]]
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has procedures at <a href="https://www.nih.gov/about-nih/visitor-information/campus-access-security">https://www.nih.gov/about-nih/visitor-information/campus-access-security</a> for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Additional Health and Safety Guidance: Before attending a
meeting at an NIH facility, it is important that visitors review the
NIH COVID-19 Safety Plan at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx</a> for information about
requirements and procedures for entering NIH facilities, especially
when COVID-19 community levels are medium or high. In addition, the
Safer Federal Workforce website has FAQs for visitors at <a href="https://www.saferfederalworkforce.gov/faq/visitors/">https://www.saferfederalworkforce.gov/faq/visitors/</a>. Please note that if an
individual has a COVID-19 diagnosis within 10 days of the meeting,
that person must attend virtually. (For more information please read
NIH's Requirements for Persons after Exposure at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx</a> and What
Happens When Someone Tests Positive at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx</a>.) Anyone from the public can attend the open
portion of the meeting virtually via the NIH Videocasting website
(<a href="http://videocast.nih.gov">http://videocast.nih.gov</a>). Please continue checking these websites,
in addition to the committee website listed below, for the most up
to date guidance as the meeting date approaches.
Information is also available on the Institute's/Center's home
page: <a href="http://www.nhlbi.nih.gov/meetings/nhlbac/index.htm">www.nhlbi.nih.gov/meetings/nhlbac/index.htm</a>, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 28, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-21422 Filed 10-3-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 4, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.